Search
for
Sort by
Research 91–120 of 777
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Baricitinib Induced Hypoglycemic Seizures in a Patient with Hair Loss and Type I Diabetes Mellitus: A Case Report
- CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1.
- Tofacitinib citrate alleviates alopecia universalis symptoms in recent case study
- Alopecia Areata of the Nails: Diagnosis and Management
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Overview of alopecia areata for managed care and payer stakeholders in the United States